Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Yue Liu, Jian-Ying Sheng, Chun-Fang Yang, Junjun Ding, Yun-Shen Chan

Clin Mol Hepatol. 2023;29(3):643-669. Published online March 6, 2023

DOI: https://doi.org/10.3350/cmh.2022.0428

View: 8284 Download: 262 Crossref: 1

Yusuke Watanabe, Atsunori Tsuchiya, Shuji Terai

Clin Mol Hepatol. 2021;27(1):70-80. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0194

View: 11643 Download: 391 Web of Science: 61 Crossref: 64

Feng Chen, Hua Wang, Jia Xiao

Clin Mol Hepatol. 2020;26(2):163-179. Published online February 27, 2020

DOI: https://doi.org/10.3350/cmh.2019.0022n

View: 9470 Download: 263 Web of Science: 4 Crossref: 3

Si Hyun Bae

Clin Mol Hepatol. 2008;14(3):309-317. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.309

View: 6356 Download: 95 Crossref: 9

1 |

Viewed By 5185	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5045	MAFLD: How is it different from NAFLD?
Viewed By 4999	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3679	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3641	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 51	MAFLD: How is it different from NAFLD?

Search